LENZ Therapeutics Inc Cash Flow-to-Debt Ratio
LENZ Therapeutics Inc cash flow-to-debt ratio. LENZ Therapeutics Inc (LENZ) has a Cash Flow-to-Debt Ratio of -2.23x as of June 2026, meaning its operating cash flow of $-38.71 Million could theoretically repay -2% of its total liabilities ($17.33 Million) in one year. See how financially flexible is LENZ Therapeutics Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of LENZ Therapeutics Inc (2019–2025)
Cash flow-to-debt ratio of LENZ Therapeutics Inc from 2019 to 2025. Historical debt coverage capacity for LENZ Therapeutics Inc across 7 annual periods. Also explore LENZ net assets growth trend to track the company's year-over-year net asset growth rate.
LENZ Therapeutics Inc Cash Flow-to-Debt Ratio by Year (2019–2025)
LENZ Therapeutics Inc cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for LENZ Therapeutics Inc. For the full cash flow conversion analysis, see cash efficiency ratio of LENZ Therapeutics Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.21x | $-69.17 Million | $21.54 Million | ▲ +39.3% |
| 2024 | -5.29x | $-59.39 Million | $11.22 Million | ▼ -1329.7% |
| 2023 | -0.37x | $-60.38 Million | $163.09 Million | ▲ +70.1% |
| 2022 | -1.24x | $-87.98 Million | $71.12 Million | ▲ +23.8% |
| 2021 | -1.62x | $-52.85 Million | $32.55 Million | ▼ -502.6% |
| 2020 | -0.27x | $-8.72 Million | $32.36 Million | ▼ -3054.2% |
| 2019 | -0.01x | $-19.00K | $2.22 Million | — |